Related Experiment Video
Updated: Jul 13, 2026
07:30
Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Are neuropsychological changes relevant in subclinical hypothyroidism?
Cloyra Almeida1, Mario Vaisman, Antonio José Leal Costa
1Endocrinology Service, HUCFF, UFRJ, Av. Brigadeiro Trompowski s/n, 21941-590 Rio de Janeiro, RJ. mleite@openlink.com.br
Arquivos Brasileiros De Endocrinologia E Metabologia
|August 9, 2007
Summary
Subclinical hypothyroidism (SH) did not show significant neuropsychological changes in patients compared to euthyroid individuals. This study found no cognitive differences in memory or vocabulary between the groups.
Area of Science:
- Endocrinology
- Neuropsychology
- Thyroid Research
Background:
- Subclinical hypothyroidism (SH) is a controversial area regarding potential neuropsychological alterations.
- Existing research on cognitive function in SH patients remains inconclusive.
Purpose of the Study:
- To investigate and assess neuropsychological changes in individuals with subclinical hypothyroidism.
- To compare cognitive performance between SH patients and healthy controls.
Main Methods:
- A cross-sectional study involving 65 SH patients and 31 euthyroid controls.
- SH defined by elevated TSH (> 4 microUI/ml) and normal free T4 (0.9-1.8 ng/dl).
- Neuropsychological assessment included memory tests (Buschkes Selective Reminding, Warrington's Recognition Memory) and vocabulary tests.
Main Results:
- No significant differences in mean age, sex, or educational level between SH patients and controls.
- No statistically significant neuropsychological deficits were identified in the SH group compared to the euthyroid group.
Conclusions:
- The study found no discernible differences in the cognitive functions assessed between patients with subclinical hypothyroidism and euthyroid individuals.
- These findings suggest that SH, within the studied parameters, may not impact cognitive performance.
Related Concept Videos
01:23Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...